GLN27GLU polymorphism in the β2-adrenergic receptor gene in patients with bronchial asthma
DOI:
https://doi.org/10.14739/2310-1210.2022.2.239468Keywords:
bronchial asthma, Gln27Glu polymorphism in the β2-adrenoceptor gene, polymorphism geneticAbstract
The aim of the study was to analyze the frequency of the polymorphism in the β2-adrenoceptor (Gln27Glu) gene in patients with bronchial asthma (BA) and to assess the association of the polymorphism with disease risks.
Materials and methods. A total of 553 patients with BA and 95 apparently healthy individuals were examined. The Gln27Glu polymorphism in the β2-АR gene (rs1042714) was determined using polymerase chain reaction-restriction fragment length polymorphism analysis. Statistical analysis of the results was performed using SPSS-17 program.
Results. The allele and genotype distribution of the Gln27Glu polymorphism in the β2-АR gene in apparently healthy individuals and BA patients was consistent with Hardy–Weinberg equilibrium (P > 0.05). The analysis revealed that heterozygotes for the Gln27Glu polymorphic variant in the β2-АR gene were more frequent among BA patients vs. apparently healthy individuals (P = 0.018). The minor allele homozygotes (Glu/Glu) were 1.5 times more frequent among BA patients vs. the controls only in terms of trends without statistical significance. There was no statistically significant difference in the genotype distribution of the studied polymorphic variant between men and women in the control group and BA patient group (P = 0.55; P = 0.47). The analysis of BA risk showed a statistically significant association within the dominant (P = 0.01), super-dominant (P = 0.02), and additive (P = 0.01) models. The minor allele carriers Glu (predominantly heterozygotes) had 1.9 times higher risk of BA in the dominant model and 1.6 times higher risk of BA in the additive model vs. the major allele homozygotes.
Conclusions. The statistically significant difference in the distribution of the homozygous and heterozygous genotypes of the β2-AR gene (Gln27Glu) polymorphism was found between asthma patients and apparently healthy individuals regardless of sex. The minor allele carriers (Gln/Glu genotypes) had the higher risk of BA vs. the major allele homozygotes.
References
Katsarou, M. S., Karathanasopoulou, A., Andrianopoulou, A., Desiniotis, V., Tzinis, E., Dimitrakis, E., Lagiou, M., Charmandari, E., Aschner, M., Tsatsakis, A. M., Chrousos, G. P., & Drakoulis, N. (2018). Beta 1, Beta 2 and Beta 3 Adrenergic Receptor Gene Polymorphisms in a Southeastern European Population. Frontiers in Genetics, 9, Article 560. https://doi.org/10.3389/fgene.2018.00560
Toraih, E. A., Hussein, M. H., Ibrahim, A., AbdAllah, N. B., Mohammad, E., Kishk, A. M., & Fawzy, M. S. (2019). Beta2-adrenergic receptor variants in children and adolescents with bronchial asthma. Frontiers in Bioscience (Elite Edition), 11(1), 61-78. https://doi.org/10.2741/E846
de Paiva, A. C., Marson, F. A., Ribeiro, J. D., & Bertuzzo, C. S. (2014). Asthma: Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene as risk factors. Allergy, Asthma & Clinical Immunology, 10(1), Article 8. https://doi.org/10.1186/1710-1492-10-8
Zhao, S., Zhang, W., & Nie, X. (2019). Association of β2-adrenergic receptor gene polymorphisms (rs1042713, rs1042714, rs1042711) with asthma risk: a systematic review and updated meta-analysis. BMC Pulmonary Medicine, 19(1), Article 202. https://doi.org/10.1186/s12890-019-0962-z
Guo, X., Zheng, H., Mao, C., Guan, E., & Si, H. (2016). An association and meta-analysis study of 4 SNPs from beta-2 adrenergic receptor (ADRB2) gene with risk of asthma in children. Asian Pacific Journal of Allergy and Immunology, 34(1), 11-20. https://doi.org/10.12932/AP0597.34.1.2016
Liang, S. Q., Chen, X. L., Deng, J. M., Wei, X., Gong, C., Chen, Z. R., & Wang, Z. B. (2014). Beta-2 Adrenergic Receptor (ADRB2) Gene Polymorphisms and the Risk of Asthma: A Meta-Analysis of Case-Control Studies. PLOS ONE, 9(8), Article e104488. https://doi.org/10.1371/journal.pone.0104488
Yu, X., Wang, L. W., He, Q., Khan, K., Chen, X. Y., & Li, J. (2019). Correlation study on β2-adrenergic receptor gene polymorphisms and asthma susceptibility: evidence based on 57 case-control studies. European Review for Medical and Pharmacological Sciences, 23(9), 3908-3925. https://doi.org/10.26355/eurrev_201905_17820
Yates, A. D., Achuthan, P., Akanni, W., Allen, J., Allen, J., Alvarez-Jarreta, J., Amode, M. R., Armean, I. M., Azov, A. G., Bennett, R., Bhai, J., Billis, K., Boddu, S., Marugán, J. C., Cummins, C., Davidson, C., Dodiya, K., Fatima, R., Gall, A., Giron, C. G., … Flicek, P. (2020). Ensembl 2020. Nucleic Acids Research, 48(D1), D682-D688. https://doi.org/10.1093/nar/gkz966
Bondarkova, A. N., Prystupa, L. N., Kartava, Y. A., & Teteruyk, A. V. (2017). Riven kontroliu bronkhialnoi astmy zalezhno vid Gln27Glu-polimorfizmu hena β2-adrenoretseptora [The control level of bronchial asthma according to Gln27Glu polymorphism β2-adrenoceptor gene]. Astma ta alerhiia, (1), 39-43. [in Ukrainian].
Slob, E., Vijverberg, S., Palmer, C., Zazuli, Z., Farzan, N., Oliveri, N., Pijnenburg, M. W., Koppelman, G. H., & Maitland-van der Zee, A. H. (2018). Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review. Pediatric Allergy and Immunology, 29(7), 705-714. https://doi.org/10.1111/pai.12956
Hikino, K., Kobayashi, S., Ota, E., Mushiroda, T., & Kobayashi, T. (2019). The Influence of Beta-2 Adrenergic Receptor Gene Polymorphisms on Albuterol Therapy for Patients With Asthma: Protocol for a Systematic Review and Meta-Analysis. JMIR Research Protocols, 8(9), Article e14759. https://doi.org/10.2196/14759
Almomani, B. A., Al-Eitan, L. N., Al-Sawalha, N. A., Samrah, S. M., & Al-Quasmi, M. N. (2019). Association of genetic variants with level of asthma control in the Arab population. Journal of Asthma and Allergy, 12, 35-42. https://doi.org/10.2147/JAA.S186252
Zhang, Y. Q., & Zhu, K. R. (2019). The C79G Polymorphism of the β2-Adrenergic Receptor Gene, ADRB2, and Susceptibility to Pediatric Asthma: Meta-Analysis from Review of the Literature. Medical Science Monitor, 25, 4005-4013. https://doi.org/10.12659/MSM.913780
Thakkinstian, A., McEvoy, M., Minelli, C., Gibson, P., Hancox, B., Duffy, D., Thompson, J., Hall, I., Kaufman, J., Leung, T. F., Helms, P. J., Hakonarson, H., Halpi, E., Navon, R., & Attia, J. (2005). Systematic Review and Meta-Analysis of the Association between β2-Adrenoceptor Polymorphisms and Asthma: A HuGE Review. American Journal of Epidemiology, 162(3), 201-211. https://doi.org/10.1093/aje/kwi184
Ferreira, M., Mathur, R., Vonk, J. M., Szwajda, A., Brumpton, B., Granell, R., Brew, B. K., Ullemar, V., Lu, Y., Jiang, Y., 23andMe Research Team, eQTLGen Consortium, BIOS Consortium, Magnusson, P., Karlsson, R., Hinds, D. A., Paternoster, L., Koppelman, G. H., & Almqvist, C. (2019). Genetic Architectures of Childhood- and Adult-Onset Asthma Are Partly Distinct. American Journal of Human Genetics, 104(4), 665-684. https://doi.org/10.1016/j.ajhg.2019.02.022
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
